PAVmed (PAVM) Minority Interest (2018 - 2026)

PAVmed has reported Minority Interest for 9 years, with the latest figure at -$15.7 million in Q2 2026.

• On a quarterly basis, Minority Interest fell 67.98% year-over-year to -$15.7 million in Q2 2026; TTM through Jun 2026 was -$15.7 million, a 67.98% decrease from a year earlier, with the FY2025 full-year figure at -$11.7 million, down 157.1% from the prior year.
• Minority Interest was -$15.7 million for Q2 2026 at PAVmed, down from -$11.7 million in the prior quarter.
• The five-year high for Minority Interest was $56.3 million in Q3 2024, with the low at -$15.7 million in Q2 2026.
• Average Minority Interest over 5 years is $17.7 million, with a median of $19.6 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Minority Interest soared 5286.81% in 2022, then plunged 157.1% in 2025.
• Over 5 years, Minority Interest stood at $20.6 million in 2022, then jumped by 44.62% to $29.8 million in 2023, then sank by 115.22% to -$4.5 million in 2024, then slumped by 157.1% to -$11.7 million in 2025, then plunged by 34.92% to -$15.7 million in 2026.
• The last three Minority Interest figures came in at -$15.7 million (Q2 2026), -$11.7 million (Q4 2025), and -$10.0 million (Q3 2025), per Business Quant data.